Simian adenovirus 41 and uses thereof
Novel simian adenovirus 41 and two isolates thereof are described. Various uses of these isolates, including construction of a recombinant vector which comprises simian adenovirus 41 sequences and a heterologous gene under the control of regulatory sequences are provided. A cell line which expresses simian adenovirus 41 gene(s) is also disclosed. Methods of using the vectors and cell lines are provided.
1. A recombinant adenovirus having a capsid comprising a hexon protein, a penton protein, and a fiber protein, said hexon protein is the SAdV-41 hexon protein with the amino acids 1 to 943 of SEQ ID NO: 11 or amino acids 1 to 943 of SEQ ID NO: 44, and said fiber protein is the fiber protein of SAdV-41.1 with the amino acids 1 to 321 of SEQ ID NO: 21 or the fiber protein of SAdV-41.2 of amino acids 1 to 325 of SEQ ID NO: 54,
said capsid encapsidating a heterologous nucleic acid comprising a gene operably linked to expression control sequences which direct transcription, translation, and/or expression thereof in a host cell.
2. The adenovirus according to claim 1 , further comprising a 5′ and a 3′ adenovirus cis-element necessary for replication and encapsidation.
3. The recombinant adenovirus according to claim 1 , wherein said recombinant adenovirus lacks all or a part of the E1 gene.
4. The recombinant adenovirus according to claim 3 , wherein said recombinant adenovirus is replication-defective.
5. The recombinant adenovirus according to claim 1 , wherein said capsid is a hybrid capsid.
6. A composition comprising the recombinant adenovirus according to claim 1 , further comprising one or more simian adenovirus proteins selected from the group consisting of:
E1a having the amino acid sequence of SEQ ID NO: 29 or SEQ ID NO: 63;
E1b, small T/19K having the amino acid sequence of SEQ ID NO: 23 or SEQ ID NO: 56;
E1b, large T/55K having the amino acid sequence of SEQ ID NO: 2 or SEQ ID NO: 35;
IX, having the amino acid sequence of SEQ ID NO: 3 or SEQ ID NO: 36;
52/55D, having the amino acid sequence of SEQ ID NO: 4 or SEQ ID NO: 37;
IIIa, having the amino acid sequence of SEQ ID NO: 5 or SEQ ID NO: 38;
Penton, having the amino acid sequence of SEQ ID NO: 6 or SEQ ID NO: 39;
VII, having the amino acid sequence of SEQ ID NO: 7 or SEQ ID NO: 40;
V, having the amino acid sequence of SEQ ID NO: 8 or SEQ ID NO: 41;
pX, having the amino acid sequence of SEQ ID NO: 9 or SEQ ID NO: 36;
VI, having the amino acid sequence of SEQ ID NO: 10 or SEQ ID NO: 43;
Endoprotease, having the amino acid sequence of SEQ ID NO: 12 or SEQ ID NO: 58;
100kD, having the amino acid sequence of SEQ ID NO: 13 or SEQ ID NO: 59;
33kD homolog, having the amino acid sequence of SEQ ID NO: 31 or SEQ ID NO: 65;
22kD, having the amino acid sequence of SEQ ID NO: 25 or SEQ ID NO: 45;
VIII, having the amino acid sequence of SEQ ID NO: 14 or SEQ ID NO: 46;
E3/12.5K, having the amino acid sequence of SEQ ID NO: 15 or SEQ ID NO: 47;
CR1-alpha, having the amino acid sequence of SEQ ID NO: 26 or SEQ ID NO: 60;
gp19K, having the amino acid sequence of SEQ ID NO: 16 or SEQ ID NO: 48;
CR1-beta, having the amino acid sequence of SEQ ID NO: 17 or SEQ ID NO: 49;
CR1-gamma, having the amino acid sequence of SEQ ID NO: 18 or SEQ ID NO: 50;
RID-alpha, having the amino acid sequence of SEQ ID NO: 19 or SEQ ID NO: 52;
RID-beta, having the amino acid sequence of SEQ ID NO: 27 or SEQ ID NO: 61; and
E3/14.7K, having the amino acid sequence of SEQ ID NO: 20 or SEQ ID NO: 53.
7. A composition comprising the recombinant adenovirus according to claim 1 in a pharmaceutically acceptable carrier.
8. The recombinant adenovirus according to claim 1 , wherein said penton protein is the penton protein of SAdV-41.1 with the amino acids 1 to 584 of SEQ ID NO: 6.
9. The recombinant adenovirus according to claim 1 , wherein said penton protein is the penton protein of SAdV-41.2 with the amino acids 1 to 584 of SEQ ID NO: 39.